CTL Medical has acquired AccelSpine, effective 25 January 2016.
“AccelSPINE is a leader in our industry, and they have a proven track record of producing exceptional medical products. Acquiring AccelSPINE not only helps advance our global growth strategy, but it also helps us meet the needs of our growing customer base,” says Andy Choi, chief business development officer for CTL Medical.
AccelSPINE was established in October 2010 by Daniel Chon, then president and chief executive officer. The company received CE marking and ISO international standard 13485 in December 2015.
The AccelSPINE brand will remain intact until the integration is complete, and all relevant regulatory measures have been met. CTL Medical will retain current AccelSPINE employees and executives, expecting to grow the workforce by early 2017.